{'output': [['Axovant Sciences Ltd', 'COMP', 'Announce', 'Negative Results', 'EVENT'], ['Axovant Sciences Ltd', 'COMP', 'Control', 'Intipirdine Program', 'CONCEPT'], ['Intipirdine Program', 'CONCEPT', 'Discontinued', None, None], ['Intipirdine Program', 'CONCEPT', 'Relate_To', 'Phase 2b Headway Study', 'EVENT'], ['Intipirdine Program', 'CONCEPT', 'Relate_To', 'Pilot Phase 2 Gait and Balance Studies', 'EVENT'], ['Intipirdine', 'PRODUCT', 'Negative_Impact_On', 'Axovant Sciences Ltd', 'COMP'], ['Nelotanserin Study', 'EVENT', 'Positive Trends', 'Efficacy', 'CONCEPT'], ['Nelotanserin Study', 'EVENT', 'Relate_To', 'Axovant Sciences Ltd', 'COMP']]}